Pituitary Tumours

Kovacs K Horvath E : Tumours of the pituitary gland. In: Hartman WH (ed): Atlas tumour of pathology. Armed Forces Institute of Pathology, Washington DC 1986: 1–264 (vol fascicle XXI).

Horvath E Kovacs K : The adenohypophysis. In: Kovacs K Asa L (eds): Functional endocrine pathology. Blackwell Science, Boston 1998: 247–281.

Ambrosi B Faglia G : Epidemiology of pituitary tumours. In: Faglia G Beck-Peccoz P (eds): Pituitary adenomas: new trends in basic and clinical research. Excerpta Medica, Amsterdam 1991. 159–169.

Molitch ME Russell EJ : The pituitary “incidentaloma”. Ann Intern Med 112: 925–391, 1990.

Teramoto A Hirakawa K : Incidental pituitary lesions in 1, 000 unselected autopsy specimens. Radiology 193:161–164, 1994.

Hall WA Luciano MG : Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120: 817–820, 1994.

Mindermann T Wilson CB : Age-related and gender-related occurrence of pituitary adenomas [published erratum appears in Clin Endocrinol (Oxf) 41(5): 700, 1994]. Clin Endocrinol (Oxf) 41: 359–364, 1994.

Shimon I Melmed S : Genetic basis of endocrine disease: pituitary tumour pathogenesis. J Clin Endocrinol Metab 82:1675–1681, 1997.

Farrell WE Clayton RN : Molecular genetics of pituitary tumours. Trends Endocrinol Metab 9: 20–26, 1998.

Alexander JM Biller BM : Clinically nonfunctioning pituitary tumours are monoclonal in origin. J Clin Invest 86: 336–340, 1990.

Herman V Fagin J : Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427–1430, 1990.

Spada A Arosio M : Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pîtuitary tumours with or without constitutively active adenylate cyclase. J Clin Endocrinol Metab 71:1421–1426, 1990.

Landis CA Harsh G : Clinical characteristics of acromegalic patients whose pituitary tumours contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416–1420, 1990.

Pernicone PJ Scheithauer BW : Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79: 804–812, 1997.

Kaltsas GA Grossman AB : Malignant pituitary tumours. Pituitary 1: 69–81, 1998.

Melmed S : Acromegaly. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 413–442.

Melmed S : Acromegaly [see comments]. N Engl J Med 322: 966–977, 1990.

Melmed S Ho K : Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 80: 3395–3402, 1995.

Ezzat S Forster MJ : Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73: 233–240, 1994.

Bertagna X Raux-Demay MC : Cushing's disease. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 478–545.

Orth DN : Cushing's syndrome [published erratum appears in N Engl J Med 332(22): 1527, 1995]. N Engl J Med 332: 791–803, 1995.

Molitch M : Prolactinoma. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 443–477.

Molitch ME : Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 80: 3–6, 1995.

Beck-Peccoz R Brucker-Davis F : Thyrotropin-secreting pituitary adenomas. Endocr Rev 17: 610–638, 1996.

Samuels MH Ridgway EC : Glycoprotein-secreting pituitary adenomas. Baillières Clin Endocrinol Metab 9: 337–358, 1995.

Chanson P : Clinically non functioning pituitary adenomas. Crit Rev One Hemat 1998: in press.

Arnold AC : Neuroophtalmologic evaluation of pituitary disorders. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 687–707.

Abboud CF : Anterior pituitary failure. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 341–410.

Pressman BD : Pituitary imaging. In: Melmed S (ed): The Pituitary. Blackwell Science, Boston 1995: 663–686.

Wolpert SM : The radiology of pituitary adenomas. Endocrinol Metab Clin North Am 16: 553–584, 1987.

Oldfield EH Chrousos GP : Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 312: 100–103, 1985.

Thapar K Kovacs K : Pituitary adenomas: current concepts in classification, histopathology, and molecular biology. The Endocrinologist 3: 39–56, 1993.

Hardy J : Transsphenoidal surgery of hypersecreting pitutary tumours. In: Kohler PO Ross GT (eds): Diagnosis and treatment of pituitary tumours. Excerpta Medica, Amsterdam 1973: 179–194.

Molitch ME Thorner MO Wilson C : Management of prolactinomas. J Clin Endocrinol Metab 82: 996–1000, 1997.

Molitch ME : Pituitary adenomas [letter; comment]. Ann Intern Med 122: 476, 1995.

Klibanski A Zervas NT : Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324: 822–831, 1991.

Laws ER Jr : Pituitary surgery. Endocrinol Metab Clin North Am 16, 1987.

Laws ER Jr Thapar K : Surgical management of pituitary adenomas. Baillières Clin Endocrinol Metab 9: 391–405, 1995.

Giovanelli M Losa M Mortini P : Surgical therapy of pituitary adenomas. Metabolism 45:115–116, 1996.

Fahlbusch R Honegger J Buchfelder M : Surgical management of acromegaly. Endocrinol Metab Clin North Am 21: 669–692, 1992.

Fahlbusch R Honegger J Buchfelder M : Acromegaly—the place of the neurosurgeon. Metabolism 45: 65–66, 1996.

Wilson CB : Extensive clinical experience: surgical management of pituitary tumours. J Clin Endocrinol Metab 82: 2381–2385, 1997.

Wilson CB : A decade of pituitary microsurgery. J Neurosurg 61: 814–833, 1984.

Chun M Masko GB Hetelekidis S : Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 15: 305–309, 1988.

Grigsby PW Stokes S : Prognostic factors and results of radiotherapy alone in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 15: 1103–1110, 1988.

Sheline G Tyrrell J : Pituitary tumours. In: Perez C Brady L (eds): Principles and practice of radiation oncology. JB Lippincott Co, Philadelphia, PA 1987: 1108–1125.

Nelson PB Goodman ML : Endocrine function in patients with large pituitary tumours treated with operative decompression and radiation therapy. Neurosurgery 24: 398–400, 1989.

Snyder PJ Fowble BF : Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 81: 457–462, 1986.

Brada M Ford D : Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304: 1343–1346, 1992.

Littley MD Shalet SM : Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 262:145–160, 1989.

Linfoot JA : Heavy ion therapy. In: Linfoot JA (ed): Recent advances in the diagnosis and treatment of pituitary tumours. Raven Press, New York, NY 1979: 245–268.

Eastman RC Gorden P : Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 21: 693–712, 1992.

Constine LS Woolf PD : Hypothalamic-pituitary dysfunction after radiation for brain tumours. N Engl J Med 328: 87–94, 1993.

Brada M Rajan B : The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38: 571–578, 1993.

Plowman PN : Radiotherapy for pituitary tumours. Baillière's Clin Endocrinol Metab 9: 407–420, 1995.

Barkan AL Halasz I : Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly [see comments]. J Clin Endocrinol Metab 82: 3187–3191, 1997.

Thorén M Rähn T : Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumours. Neurosurgery 29: 663–668, 1991.

Pollock BE Kondziolka D : Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir Suppl (Wien) 62: 33–38, 1994.

Sheline GE . Proceedings: Treatment of nonfunctioning chromophobe adenomas of the pituitary. Am J Roentgenol Radium Ther Nucl Med 120: 553–561, 1974.

Tsang RW Laperriere NJ : Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk [published erratum appears in Cancer 73(2): 492, 1994]. Cancer 72: 2227–2233, 1993.

Thorner M Vance ML : The anterior pituitary. In: Wilson JD Foster DW (eds): Williams Textbook of Endocrinology. WB Saunders, Philadelphia, PA 1998: 249–340.

Lamberts SW Hofland LJ : Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol 14: 27–55, 1993.

Lamberts SW van der Lely AJ : Octreotide. N Engl J Med 334: 246–254, 1996.

Vance ML Evans WS Thorner MO : Drugs five years later. Bromocriptine. Ann Intern Med 100: 78–91, 1984.

Liuzzi A Dallabonzana D : Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 313: 656–659, 1985.

Bevan JS Webster J : Dopamine agonists and pituitary tumour shrinkage. Endocr Rev 13: 220–240, 1992.

Molitch ME : Pregnancy and the hyperprolactinemic woman. N Engl J Med 312: 1364–1370, 1985.

Kupersmith MJ Rosenberg C Kleinberg D : Visual loss in pregnant women with pituitary adenomas [see comments]. Ann Intern Med 121: 473–477, 1994.

Gemzell C Wang CF : Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 31: 363–372, 1979.

van't Verlaat JW Croughs RJ Brownell J : Treatment of macroprolactinomas with a new non-ergot, long-acting dopaminergic drug, CV 205-502. Clin Endocrinol (Oxf) 33: 619–624, 1990.

Duranteau L Chanson P : Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas. Clin Endocrinol (Oxf) 34: 25–29, 1991.

Brue T Pellegrini I : Effects of the dopamine agonist CV 205–502 in human prolactinomas resistant to bromocriptine. J Clin Endocrinol Metab 74: 577–584, 1992.

Vilar L Burke CW : Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine [see comments]. Clin Endocrinol (Oxf) 41: 821–826, 1994.

Rains CP Bryson HM Fitton A : Cabergoline: a review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinæmia and inhibition of lactation. Drugs 49: 255–279, 1995.

Webster J Piscitelli G : A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group [see comments]. N Engl J Med 331: 904–909, 1994.

Biller BM Molitch ME : Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81: 2338–2343, 1996.

Colao A Di Sarno A : Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment [see comments]. J Clin Endocrinol Metab 82: 876–883, 1997.

Colao A Di Sarno A : Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82: 3574–3579, 1997.

Jaffe CA Barkan AL : Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 21: 713–735, 1992.

Miller JW Crapo L : The medical treatment of Cushing's syndrome. Endocr Rev 14: 443–458, 1993.

Chanson P Timsit J Harris AG : Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet 25: 375–391, 1993.

Sassolas G Harris AG James-Deidier A : Long term effect of incremental doses of the somatostatin analog SMS 201–995 in 58 acromegalic patients. French SMS 201–995 Acromegaly Study Group. J Clin Endocrinol Metab 71: 391–397, 1990.

Vance ML Harris AG : Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group. Arch Intern Med 151:1573–1578, 1991.

Ezzat S Snyder PJ : Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 117:711–718, 1992.

Newman CB Melmed S : Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients—a clinical research center study [published erratum appears in J Clin Endocrinol Metab 80(11): 3238, 1995]. J Clin Endocrinol Metab 80: 2768–2775, 1995.

Gillis JC Noble S Goa KL : Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs 53: 681–699, 1997.

Heron I Thomas F : Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly. J Clin Endocrinol Metab 76: 721–727, 1993.

Morange I De Boisvilliers F : Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. J Clin Endocrinol Metab 79:145–151, 1994.

Giusti M Gussoni G : Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group [see comments]. J Clin Endocrinol Metab 81: 2089–2097, 1996.

Caron P Morange-Ramos I : Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide [see comments]. J Clin Endocrinol Metab 82: 18–22, 1997.

Chanson P Weintraub BD Harris AG : Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119: 236–240, 1993.

Gancel A Vuillermet P : Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 40: 421–428, 1994.

Warnet A Timsit J : The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. J Neurosurg 71: 687–690, 1989.

Warnet A Harris AG : A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. Neurosurgery 41: 786–797, 1997.

Krenning EP Kwekkeboom DJ : Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716–731, 1993.

Chanson P : Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits? [comment]. Eur J Endocrinol 136: 359–361, 1997.

Ebersold MJ Quast LM : Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64: 713–719, 1986.

Harris PE Afshar F : The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 71: 417–427, 1989.

Comtois R Beauregard H : The clinical and endocrine outcome to transphenoidal microsurgery of non secreting pituitary adenomas. Cancer 68: 860–866, 1991.

Sassolas G Trouillas J : Management of non-functioning pituitary adenomas. Acta Endocrinol 129 (suppl 1): 21–26, 1993.

Hayes TP Davis RA Raventos A : The treatment of pituitary chromophobe adenomas. Radiology 98: 149–153, 1971.

Ciric I Mikhael M : Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59: 395–401, 1983.

Vlahovitch B Reynaud C : Treatment and recurrences in 135 pituitary adenomas. Acta Neurochir 42 (Suppl): 120–123, 1988.

Jaffrain-Rea ML Derome P : Influence of radiotherapy on long-term relapse in clinically non- secreting pituitary adenomas. A retrospective study (1970–1988). Eur J Med 2: 398–403, 1993.

Bradley KM Adams CBT : An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol 41: 655–659, 1994.

Gittoes NJL Bates AS : Radiotherapy for non-functioning pituitary tumours. Clinical Endocrinology 48: 331–337, 1998.

Rosen T Bengtsson A-G : Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336: 285–288, 1990.

Bates AS Van't Hoff W : The effects of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81: 1169–1172, 1996.

Bülow B Hagmar L : Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 46: 75–81, 1997.

Frohman LA : Acromegaly: what constitutes optimal therapy? [editorial]. J Clin Endocrinol Metab 81: 443–445, 1996.

Bates AS Van't Hoff W : An audit of outcome of treatment in acromegaly. Q J Med 86: 293–299, 1993.

Rajasoorya C Holdaway IM : Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41: 95–102, 1994.

Roelfsema F van Dulken H Frolich M : Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf) 23: 555–565, 1985.

Sheaves R Jenkins P : Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 45: 407–413, 1996.

Yamada S Aiba T : Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome. Clin Endocrinol (Oxf) 45: 291–298, 1996.

Colao A Ferone D : Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 82: 3308–3314, 1997.

Colao A Merola B : Acromegaly. J Clin Endocrinol Metab 82: 2777–2781, 1997.

Buchfelder M Fahlbusch R : Neurosurgical treatment of Cushing's disease in children and adolescents. Acta Neurochir Suppl (Wien) 35: 101–105, 1985.

Losa M Oeckler R : Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. J Neurosurg 70: 561–567, 1989.

Lamberg BA Kivikangas V : Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion. Acta Endocrinol (Copenh) 82: 267–281, 1976.

Feek CM McLelland J : How effective is external pituitary irradiation for growth hormone- secreting pituitary tumours? Clin Endocrinol (Oxf) 20: 401–408, 1984.

Kliman B Kjellberg RN : Long-term effects of proton-beam therapy for acromegaly. In: Robbins RJ Melmed S (eds): Acromegaly. Plenum Press, New York 1986: 221–228.

Speirs CJ Reed PI : The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinol (Copenh) 122: 559–565, 1990.

Chanson P Grellier-Fouqueray P : Comment et avec quelle efficacité traite-t-on l'acromégalie en 1997? Enquête transversale sur une population de 74 acromégales (Abst). Ann Endocrinol (Paris) 58 (Suppl 2): 2S69, 1997.

Arosio M Macchelli S : Effects of treatment with octreotide in acromegalic patients - a multicenter Italian study. Italian Multicenter Octreotide Study Group. Eur J Endocrinol 133: 430–439, 1995.

Fløgstad AK Halse J : Sandostatin LAR in acromegalic patients: long-term treatment [see comments]. J Clin Endocrinol Metab 82: 23–28, 1997.

Lancranjan I Bruns C : Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism 45: 67–71, 1996.

Stewart PM Kane KF : Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly. J Clin Endocrinol Metab 80: 3267–3272. 1995.

Feigenbaum SL Downey DE : Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. J Clin Endocrinol Metab 81: 1711–1719, 1996.

Thomson JA Davies DL : Ten year follow up of microprolactinoma treated by transsphenoidal surgery. Bmj 309: 1409–1410, 1994.

Serri O Hardy J Massoud F : Relapse of hyperprolactinemia revisited [letter]. N Engl J Med 329: 1357, 1993.

Grossman A Cohen BL : Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) 288: 1105–1109, 1984.

Nabarro JD : Pituitary prolactinomas. Clin Endocrinol (Oxf) 17: 129–155, 1982.

Tsagarakis S Grossman A : Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up. Clin Endocrinol (Oxf) 34: 399–406, 1991.

Arnott RD Pestell RG : A critical evaluation of transsphenoidal surgery in the treatment of Cushing's disease: prediction of outcome. Acta Endocrinol (Copenh.) 123: 423–430, 1990.

Bochicchio D Losa M Buchfelder M : Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group [see comments]. J Clin Endocrinol Metab 80: 3114–3120, 1995.

Guilhaume B Bertagna X : Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 66: 1056–1064, 1988.

Mampalam TJ Tyrrell JB Wilson CB : Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 109: 487–493, 1988.

Burke CW Adams CB : Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf) 33: 525–537, 1990.

Post KD Habas JE : Comparison of long term results between prolactin secreting adenomas and ACTH secreting adenomas. Can J Neurol Sci 17: 74–77, 1990.

Tindall GT Herring CJ : Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg 72: 363–369, 1990.

Robert F Hardy J : Cushing's disease: a correlation of radiological, surgical and pathological findings with therapeutic results. Pathol Res Pract 187: 617–621, 1991.

Tahir AH Sheeler LR : Recurrent Cushing's disease after transsphenoidal surgery. Arch Intern Med 152: 977–981, 1992.

Trainer PJ Lawrie HS : Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment [see comments]. Clin Endocrinol (Oxf) 38: 73–78, 1993.

Ram Z Nieman LK : Early repeat surgery for persistent Cushing's disease. J Neurosurg 80: 37–45, 1994.

Styne DM Grumbach MM : Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med 310: 889–893, 1984.

Dyer EH Civit T : Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 34: 207–212; discussion 212, 1994.

Leinung MC Kane LA : Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. J Clin Endocrinol Metab 80: 2475–2479, 1995.

Magiakou MA Mastorakos G : Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331: 629–636, 1994.

Howlett TA Plowman PN : Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up. Clin Endocrinol (Oxf) 31:309–323, 1989.

Estrada J Boronat M : The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease [see comments]. N Engl J Med 336: 172–177, 1997.

Tyrrell JB Wilson CB : Cushing's disease. Therapy of pituitary adenomas. Endocrinol Metab Clin North Am 23: 925–938, 1994.

Etxabe J Vazquez JA : Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40: 479–484, 1994.

De Boer H Blok GJ van der Veen EA : Clinical aspects of growth hormone in adults. Endocrine Rev 16: 63–86, 1995.

Melmed S : The Pituitary. Blackwell Science, Boston, MA 1995.